Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage...

by Ma Honglian, Hui Zhouguang, PENG Fang, Zhao Lujun, Li Dongming, Xu Yujin, Bao Yong, Xu Liming, Zhai Yirui, Hu Xiao, Wang Jin, Kong Yue, Wang Lvhua, Chen Ming
Published 2020-04-01